Summary
Overview
Work History
Education
Skills
Advisory Board Experience
Timeline
Receptionist
Jason Drenning

Jason Drenning

Colleyville,TX

Summary

President, CEO, and Advisory Board Member with two decades of life sciences experience. Dynamic leader with focus on building high performing work culture. Strategic collaborator, with strong track record in starting and scaling businesses globally.

Overview

18
18
years of professional experience

Work History

President & CEO

STATinMED
Dallas, TX
05.2024 - Current
  • Grew revenue by 60% in 2025
  • Grew EBITDA by 55% in 2025
  • Developed new suite of digital market access products to adapt/adjust to changing life sciences landscape
  • Driving enterprise level sales growth through thought leadership
  • Rebranding our products to streamline naming and strategic vertical within pharma/device/biotech
  • Engaging with investors to identify new areas of opportunity for M&A
  • Identifying key strategic healthcare partners to expand offerings

CCO/COO

STATinMED
Dallas, TX
11.2021 - 05.2024
  • Engaging with investors to establish strategic growth, operations, and sales plan
  • Created Client Engagement division to drive project/customer service excellence
  • Led rebranding of company website, logo, content development
  • Developed enterprise/platform offering, including the successful sale of first enterprise deal in history of STATinMED for $1.6M
  • Sales lead on channel partner deal for $1.4M; recurring, quarterly revenue w/100% margin
  • Working with CEO to create additional value for company, specific to new product offerings
  • Grew customer footprint from large pharma only, to small & medium Pharma, and non-Pharma (from 15 to 42 customers)

Senior Vice President, Corporate Development & Operations

STATinMED
Dallas, TX
11.2020 - 11.2021
  • Leading all operational aspects of the business including research and programming.
  • Leading all corporate development, sales, and marketing functions.
  • Achieved Q4 2020, Q1 2021, Q2 2021, and Q3 sales forecasts.
  • Q2 2021 sales = most in the history of STATinMED with 80% growth YoY
  • Established 7 person team of highly skilled, highly motivated sales executives
  • Sales enablement division created to drive proposals, sales support, patient counts
  • Operational turnaround resulted in consistent revenue model with monthly targets hit in consecutive months from September to present.

Vice President, Business Development

STATinMED
Dallas, TX
02.2020 - 11.2020
  • Led team of BD executive in driving new business through insight centric approach
  • Added new data assets in oncology and EMR data
  • Went from $0 to $2M in 2020 at Gilead via multiple projects in partnership model
  • Established thought leadership presence for company through videos/blogs/publication planning
  • Identified key strategic partnerships with Parexel, Joint Man, Vanderbilt University, and M2GEN
  • Expanded account at Takeda beyond GI into oncology and rare heme
  • Began operational oversight of research and turned around failing revenue model

Senior Director, HEOR Operations

CONCERTO HEALTH AI
03.2019 - 02.2020
  • Establish operational processes for new HEOR project types
  • Implement work flows to support project work using Outcomes data products for nonsubscribers, not requiring custom curation
  • Implement work flows to support project work requiring incremental curation on subsets of Outcomes data product cases for subscribers
  • Implement new analytic models leveraging linked EMR-Claims data products
  • Management for statistical programming services
  • Establish and direct a pharma-facing FSP model to provide HEOR scientific and programming services
  • Build new processes to allow scalability of HEOR project work
  • Identify and hire the right people in US and off-shore to support new HEOR project models
  • Align operational processes with CSO to optimize scientific input into proposal and delivery of each project type
  • Work closely with CSO to scale the feasibility/proposal unit to increase flow of new proposals
  • Work with President, Sales VP, CSO and CFO to implement processes and systems coordinating proposals, backlog/pipeline, revenue forecasting and resource planning between sales/BD, HEOR operations and finance teams
  • Align and optimize processes with the HEOR scientific team as needed to meet delivery of project milestones, and adoption of Outcomes data products
  • Drive HEOR team adoption of new technology tools for HEOR adopted and implemented in the eureka platform
  • Direct Project Management team
  • Connect with other CHAI service areas as needed to align products and service offerings (e.g. Eureka platform team, Global Curation Services)
  • Contribute to achievement of Outcomes Science Bookings, NOR, GM and P&L goals.
  • Support President and CFO in monthly management reporting.

Director, Strategic Accounts

IQVIA (IMS-Quintiles)
Dallas, TX
03.2018 - 03.2019
  • Managing relationships and expanding accounts for drug wholesaler/suppliers
  • Verticals into HEOR, distribution sales, hub services, and analytics
  • Working strategically with customers to understand data needs
  • Developing reports to meet customer objectives based on data strategy
  • Expanding networks to identify areas of unmet opportunities for data and reports
  • Attending wholesaler/supplier sales meetings to partner with customers and better understand business needs
  • Growing account by expanding relationships outside of pharmacies, pharma, and physicians
  • Selling data, reporting, and insight-centric solutions

Head of Clinical Operations

Cardinal Health
Dallas, TX
10.2016 - 03.2018
  • Established new value proposition for Pharma Hub business, focused on analytics/data insights
  • Thought leadership development for new value prop including publications and presentations (Speaker at Pharma 4 and CBI Conferences)
  • Casting vision for integration of patient reported outcomes (PRO) and data aggregation product offerings into Pharma Hub space
  • Developing and selling PRO product offering as differentiator for Cardinal Hub
  • Working strategically with Pharma manufacturers to provide brand strategy solutions using Hub data
  • Rebuilding client relations group to drive consultative account management via data driven insights
  • Developing processes for sales pursuit, QBR meetings, report dissemination to clients
  • Responsible for Pharma Hub (Access and Patient Services-Sonexus) P&L analytics
  • Leading process optimization to drive EBIT
  • Ensuring interdepartmental efficiencies between IT, operations, finance, and sales
  • Facilitating interconnected communication across business

Director, HEOR

Cardinal Health
Dallas, TX
02.2015 - 10.2016
  • Responsible for management, fiscal growth, marketing plan, and operations of the Cardinal Health HEOR consulting business
  • Developed new product offerings in the HEOR space
  • Built new function of client relations/engagement within the business
  • Achieved profitability for first time in history of HEOR business at Cardinal Health (started in 2011)
  • Led turnaround of business, going from revenue of $2M to revenue of $7M, including GM increase from 0% to 136%
  • Led publications and thought leadership marketing strategy for Specialty Solutions division, increasing volume of acceptances by 125%
  • Selected as one of 32 Directors across the Cardinal Health enterprise to participate in the Innovate leadership development program for high potential-high performers.
  • Reviewed new business opportunities, oversight and accountability for project timelines, management of operations teams, support of physician leaders, and ensuring quality conduct and successful execution of Healthcare Analytics projects
  • Worked collaboratively with contracting, finance, and BD teams in order to manage timelines, and all needs related to the operations of projects
  • Planned FY budgets, revenue projections and assisted with forecasting of activities (costs) for clients
  • Worked proactively with the Business Development team to provide support on the offerings of the businesses, review of proposals, created scopes of work for vendors and clients and defined/refined service lines
  • Managed the business feasibility process, including use of multiple data assets and knowledge sources
  • Chief of Staff for Division President’s Operating Committee

Director, Scientific Communications

Cardinal Health
Dallas, TX
08.2013 - 02.2015
  • Established SciComm team as a go-to insight generating group, serving the Marketing Communications consulting business within Cardinal Health Specialty Solutions
  • Cardinal Health Specialty Solutions’ Rising Star for fiscal year 2014 (July ’13 to June ’14)
  • Developed insight driven lead marketing initiative to deliver analytics insights to support consulting business development/sales
  • Led, planned, and executed strategic publication planning effort across Pharma Specialty Solutions division, in collaboration with Chief Medical Officer
  • Executive Director and founder of FOCUS magazine, a Cardinal Health - HEOR bi-annual thought leadership marketing piece
  • Built cohesive, high-performing Scientific Communications team to serve Specialty Solutions division, and establish thought leadership in specialty drug market
  • Providing strategic, scientific vision for top-to-top executive meeting agendas with Pfizer, Genentech, Novartis, Sanofi, Amgen, and Astrazeneca
  • Establishing strategic meeting agendas for Division President’s Specialty Operating Committee
  • Chief of Staff for Division President’s Specialty Operating Committee
  • Developing relationships with clinical thought leaders in the oncology, hematology, and urology therapeutic areas arenas to stay current on clinical developments
  • Working cross functionally with all other Specialty Solutions business units to leverage insights from scientific communications for business development

Clinical Operations Manager

Orthofix
Lewisville, TX
04.2012 - 08.2013
  • Strategic scientific communication planning and execution for reimbursement presentations to medical directors (i.e. Blue Cross Blue Shield), and scientific presentations for global conferences and congresses
  • Presented clinical data at international research forums (i.e. World Forum for Spine Research – Helsinki)
  • One of two total (out of 800 employees) LEAN process efficiency award winners at OFIX – Purple Belt
  • Identifying and negotiating with CRO for post market studies to maintain CE mark
  • HEOR study planning and execution based on business needs, target journal etc.
  • Developed regional strategic marketing plan based on leveraging clinical data to target specific US areas
  • Worked closely with marketing department to develop key marketing materials for sales force focused on clinical data and publications
  • Identify products where published clinical data would increase market share
  • Planned and executed on strategies to publish retrospective clinical data to show evidence of value in products needing leverage

Senior Manager, Global Quality, Regulatory, and Clinical Affairs

Wright Medical Technology
Amsterdam
09.2011 - 03.2012
  • Led launch of Global Quality, Regulatory, and Clinical group based in Amsterdam
  • Resolved difficult compliance, clinical, and regulatory issues through successful coalition building
  • Led global, interdepartmental product obsolescence effort based on myriad of business concerns including gross profit margins and clinical trial costs
  • Designed and implemented clinical/regulatory strategies to obtain, maintain, and extend product registrations
  • Involved in the creation and submission of documents to global regulatory authorities and notified body (e.g. FDA, BSi etc.)
  • Served as a liaison with global regulatory authorities to develop effective relationships; Arranged and led meetings with global regulatory authorities
  • Developed clinical trial protocols for global studies to maintain CE mark
  • Participated in the assessment, qualification, and recommendation of clinical trial vendors (e.g., CROs, laboratories, etc.)
  • Monitored progress of clinical trials and how they are conducted, recorded and reported versus the protocol, standard operating procedures (SOP), good clinical practices (GCP), other applicable regulatory requirements and timelines

Senior Manager, Strategic Scientific Communications

Wright Medical Technology
03.2010 - 09.2011
  • Led launch of global department of strategic scientific communications/HEOR group
  • Established strategies and tactics supporting core components of scientific communications, including: development of marketing materials, disease education programs, scientific exchange tools/resources, medical meeting/congress communications, publications and medically/scientifically oriented advisory boards
  • Established and maintained a global network of key opinion leaders, supplemented by functional relationships with key societies and organizations
  • Developed and led a comprehensive, global scientific communications strategy for launch of wound care product
  • Worked closely with Clinical, Regulatory, and R&D groups in EMEA to determine business needs via product optimization, gross margins, and market trends
  • Served as liaison to notified body in EMEA
  • Successful author of $2.4 million Department of Defense (DoD) grant for IDE clinical trial on calcium sulfate based bone void filler coated with tobramycin
  • Project lead on pre-IDE meeting, IDE submission, and negotiation with FDA on protocol for DoD study
  • Developed sales training program specific to publications/scientific communications
  • Developed online resource library as means to equip/educate sales force

Publications Manager

Wright Medical Technology
07.2009 - 03.2010
  • Planned for launch of Strategic Scientific Communications group within Clinical Affairs department
  • Worked closely with sales force to develop marketing/educational materials for Ortho Recon products
  • Met with key opinion leaders to discuss strategic publication plans
  • Helped drive important business objectives through publications on Ortho Recon products
  • Managed seven retrospective clinical trials, each resulting in manuscripts
  • Author and Project Director for grant application to Department of Defense resulting in $2.4 million for clinical trial to study open fracture wound treatment
  • Worked with Chief Compliance Officer to develop foundational procedures to plan launch of in-house publications group
  • Wrote and edited post market clinical follow up plans for dossier submissions to notified body in Europe

Clinical Project Manager

Exactech
Gainesville, FL
05.2008 - 06.2009
  • Designed educational curriculum for sales staff
  • Study manager for FDA regulated post market approval study and multiple clinical studies
  • Study monitor for FDA and non-FDA regulated clinical studies
  • Author and Project Director – Small Business Innovative Research (SBIR) Grant
  • $850k in funding
  • Initiated project ideas, and assembled team of scientists and product managers
  • Served as biostatistician for all company related clinical studies and preclinical analyses
  • Avoided 3rd party contracting and saved company over 35k in first year
  • Met with key opinion leaders to discuss both current and potential future projects
  • Wrote and edited 510k, and PMA submissions to FDA
  • Wrote and edited post market clinical follow up plans for dossier submissions to notified body in Europe

Education

Innovate – Cardinal Health Executive Program - undefined

Vanderbilt University
01.2016

Certificate in Finance and Accounting - undefined

Southern Methodist University
01.2015

PhD - Molecular Physiology

University of Florida
01.2008

MS - Clinical Physiology

George Washington University
01.2000

BS - Physiology

George Washington University
01.1997

Skills

  • Life Sciences
  • Customer Engagement
  • Conflict Resolution
  • EBITDA Improvement
  • High Performance Team Building
  • Coaching
  • Talent Identification
  • Private Equity
  • Operational Strategy

Advisory Board Experience

  • STATinMED, 2021-11-01
  • Iluria, 2025-02-01
  • CarePoint Solutions, 2025-01-01

Timeline

President & CEO

STATinMED
05.2024 - Current

CCO/COO

STATinMED
11.2021 - 05.2024

Senior Vice President, Corporate Development & Operations

STATinMED
11.2020 - 11.2021

Vice President, Business Development

STATinMED
02.2020 - 11.2020

Senior Director, HEOR Operations

CONCERTO HEALTH AI
03.2019 - 02.2020

Director, Strategic Accounts

IQVIA (IMS-Quintiles)
03.2018 - 03.2019

Head of Clinical Operations

Cardinal Health
10.2016 - 03.2018

Director, HEOR

Cardinal Health
02.2015 - 10.2016

Director, Scientific Communications

Cardinal Health
08.2013 - 02.2015

Clinical Operations Manager

Orthofix
04.2012 - 08.2013

Senior Manager, Global Quality, Regulatory, and Clinical Affairs

Wright Medical Technology
09.2011 - 03.2012

Senior Manager, Strategic Scientific Communications

Wright Medical Technology
03.2010 - 09.2011

Publications Manager

Wright Medical Technology
07.2009 - 03.2010

Clinical Project Manager

Exactech
05.2008 - 06.2009

Innovate – Cardinal Health Executive Program - undefined

Vanderbilt University

Certificate in Finance and Accounting - undefined

Southern Methodist University

PhD - Molecular Physiology

University of Florida

MS - Clinical Physiology

George Washington University

BS - Physiology

George Washington University